AgreementAgreement • October 29th, 2008 • Celgene Corp /De/ • Pharmaceutical preparations • New York
This Agreement is entered into as of October 3, 2008 (the “Termination Date”), by and between PHARMION LLC, a Delaware limited liability company having an address of 2525 28th Street, Suite 200, Boulder, Colorado 80301 (“Pharmion LLC”), the successor in interest to PHARMION CORPORATION, PHARMION SÀRL, a Swiss limited liability company and the successor in interest to PHARMION GMBH, a wholly-owned subsidiary of Pharmion LLC, having an address of Route de Perreux 1, 2017 Boudry, Switzerland (“Pharmion Sàrl” and, together with Pharmion LLC, “Pharmion”), and CELGENE CORPORATION, a Delaware corporation, having an address of 86 Morris Avenue, Summit, New Jersey 07901 (“Celgene”), and PHARMACIA & UPJOHN COMPANY LLC (formerly Pharmacia & Upjohn Company), a Delaware limited liability company having and address of 235 East 42nd Street, New York, New York 10017 (“Pharmacia”). Pharmion, Celgene and Pharmacia each may be referred to herein individually as a “Party,” or collectively as the “Parties.
